Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	0.38	45.61	45.43
Graham Fair Price	-5.40	17.52	18.52
PEG	0.94	-1.55	-1.57
Price/Book	11.21	2.31	2.07
Price/Cash Flow	-48.33	75.96	147.00
Prices/Earnings	24.43	22.48	18.06
Price/Sales	5.01	3.84	3.65
Price/FCF	-48.33	75.96	147.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.35	0.37	0.40
Operating Margin	11.61	0.09	0.08
ROA	-11.85	0.01	0.01
ROE	0.03	0.03	-10.62
ROIC	0.02	0.02	12.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	52.39
Dividends QOQ	0.08	0.01	-82.42
EBIT QOQ	-0.10	0.18	79.34
EPS QOQ	-0.12	-0.14	-25.60
FCF QOQ	-0.75	1.15	53.85
Revenue QOQ	-0.02	0.06	207.26
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	133.63	120.53	-9.81
Days Sales Outstanding (DSO)	29.95	33.83	12.97
Inventory Turnover	0.67	0.75	10.87
Debt/Capitalization	0.48	0.42	-11.89
Quick Ratio	0.44	0.57	28.69
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23.05	23.06	0.06
Cash	1.12	1.29	15.60
Capex	-0.47	-0.25	47.10
Free Cash Flow	0.33	0.70	115.34
Revenue	13.08	13.86	5.97
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.47	1.70	15.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.38	12.34	-7.78
Naive Interpretation	Member

06 - Financial Health · Weak

Rating